Brinker Capital’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $1.61M | Buy |
+6,028
| New | +$1.61M | 0.05% | 364 |
|
|
2018
Q4 | – | Sell |
-2,562
| Closed | -$905K | – | 876 |
|
|
2018
Q3 | $905K | Buy |
2,562
+224
| +10% | +$79.1K | 0.03% | 524 |
|
|
2018
Q2 | $679K | Sell |
2,338
-229
| -9% | -$66.5K | 0.03% | 615 |
|
|
2018
Q1 | $703K | Buy |
2,567
+100
| +4% | +$27.4K | 0.03% | 593 |
|
|
2017
Q4 | $786K | Sell |
2,467
-2,680
| -52% | -$854K | 0.03% | 527 |
|
|
2017
Q3 | $1.61M | Buy |
+5,147
| New | +$1.61M | 0.07% | 275 |
|
|
2017
Q2 | – | Sell |
-2,248
| Closed | -$615K | – | 675 |
|
|
2017
Q1 | $615K | Sell |
2,248
-1,248
| -36% | -$341K | 0.03% | 544 |
|
|
2016
Q4 | $991K | Buy |
3,496
+1,396
| +66% | +$396K | 0.06% | 307 |
|
|
2016
Q3 | $657K | Sell |
2,100
-152
| -7% | -$47.6K | 0.06% | 132 |
|
|
2016
Q2 | $545K | Sell |
2,252
-28
| -1% | -$6.78K | 0.05% | 192 |
|
|
2016
Q1 | $593K | Buy |
2,280
+755
| +50% | +$196K | 0.05% | 153 |
|
|
2015
Q4 | $467K | Buy |
+1,525
| New | +$467K | 0.04% | 136 |
|
|
2015
Q3 | – | Sell |
-15,209
| Closed | -$6.14M | – | 118 |
|
|
2015
Q2 | $6.14M | Buy |
15,209
+13,634
| +866% | +$5.51M | 0.52% | 41 |
|
|
2015
Q1 | $665K | Sell |
1,575
-98
| -6% | -$41.4K | 0.06% | 81 |
|
|
2014
Q4 | $568K | Buy |
1,673
+58
| +4% | +$19.7K | 0.05% | 106 |
|
|
2014
Q3 | $534K | Buy |
1,615
+16
| +1% | +$5.29K | 0.04% | 85 |
|
|
2014
Q2 | $504K | Buy |
1,599
+173
| +12% | +$54.5K | 0.03% | 99 |
|
|
2014
Q1 | $436K | Sell |
1,426
-182
| -11% | -$55.6K | 0.04% | 121 |
|
|
2013
Q4 | $449K | Sell |
1,608
-128
| -7% | -$35.7K | 0.04% | 106 |
|
|
2013
Q3 | $417K | Buy |
1,736
+189
| +12% | +$45.4K | 0.04% | 92 |
|
|
2013
Q2 | $332K | Buy |
+1,547
| New | +$332K | 0.04% | 114 |
|